2 hrs ago
Effect of High-Dose Atorvastatin on Renal Function in Subjects With...
Department of Neurology and Stroke Center, Paris-Diderot Sorbonne University, Paris, France ; Department of Neurology, Vanderbilt University, Nashville, TN ; Division of Nephrology and Hypertension Center, USC/Keck School of Medicine, Los Angeles, CA ; Department of Neurology, Duke University Medical Center, Durham, NC ; Department of Neurology, ... (more)
Mon Aug 18, 2014
People's Pharmacy: Statins may have neurological side effects
Years ago, my mother, who was a nurse, used Vicks VapoRub almost as a cure-all for us children.
Statin drugs may help fight Ebola
Statin medications used to treat people with heart disease and diabetes may help fight Ebola , according to physicians writing an editorial in a recent edition of the New York Times .
Sun Aug 17, 2014
The Town Talk
Roach: Some statins can cause memory lossRoach: Some statins can...
Roach: Some statins can cause memory loss Dear Dr. Roach: I have been taking Lipitor for high cholesterol.
Wed Aug 13, 2014
San Fernando Sun
We Can Do Much to Hold Down Medication Costs
Recently, the National Institutes of Health urged physicians to prescribe a water pill, called hydrochlorothiazide, as the initial treatment for hypertension.
Tue Aug 12, 2014
The preventive effect of atorvastatin on atrial fibrillation: a...
A number of clinical and experimental studies have investigated the effect of atorvastatin on atrial fibrillation , but the results are equivocal.
Personal Injury Law News
Lipitor Lawsuit News: Bernstein Liebhard LLP Notes Growing Number of...
The Firm is evaluating Lipitor lawsuits on behalf of individuals who allegedly developed Type 2 diabetes due to their use of the cholesterol-lowering statin.
US News & World Report
Should You Be Taking a Statin?
With new guidelines for the prevention of heart disease, the number of people using statin - a cholesterol-lowering drug - is projected to double.
Mon Aug 11, 2014
Time To Panic Over Lipitor Litigation?
Lipitor is the best selling prescription drug ever and one of the most advertised drugs.
Sun Aug 10, 2014
Lipitor Lawsuits Among Women Soar in Past 5 Months
Lawsuits by U.S. women who blame Lipitor for their type 2 diabetes have soared over the past 5 months, from 56 to nearly 1000 cases representing 4000 women, according to a Reuters investigation.
Thousands of women sue Pfizer over Lipitor
Thousands of women sue Pfizer over Lipitor . More than 4,000 women in the United States filed lawsuits in federal court claiming Lipitor caused them to develop Type-2 diabetes .
Sat Aug 09, 2014
Synthesis of deuterium-labeled atorvastatin and its metabolites for...
To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document.
Fri Aug 08, 2014
Rosuvastatin Activates ATP-Binding Cassette Transporter A1-Dependent...
From the Departments of Cardiology , Molecular Cardiovascular Therapeutics , Biochemistry , and Advanced Therapeutics for Cardiovascular Disease , Fukuoka University School of Medicine, Fukuoka, Japan.
Thu Aug 07, 2014
Pfizer confronts surge of lawsuits over Lipitor
In the past five months, a Reuters review of federal court filings shows, lawsuits by U.S. women who say that taking Lipitor gave them type-2 diabetes have shot up from 56 to almost 1,000.
Tue Aug 05, 2014
Statin Benefits Far Outweigh Side Effects: Johns Hopkins
The benefits of long-term use of cholesterol-lowering statin drugs greatly outweigh the risks, according to a review of research published over 20 years.
Mon Aug 04, 2014
Statins May Aid Survival From Colon Cancer
Statins, the widely used cholesterol-lowering drugs, may also boost colorectal cancer survival, according to a new U.K. study.
Atorvastatin calcium plus amlodipine for the treatment of hypertension.
Hypertension and dyslipemia are two of the major modifiable cardiovascular risk factors, determinants in the development of cerebrovascular and coronary heart disease .
Combined Administration of RG7652, a Recombinant Human Monoclonal...
To whom correspondence should be addressed at: Genentech Inc., MS no. 59, South San Francisco, CA 94080.
Fri Aug 01, 2014
Medical News Today
Sanofi and Regeneron report positive top-line results from nine phase ...
Sanofi and Regeneron Pharmaceuticals, Inc. have announced that nine new Phase 3 ODYSSEY trials of alirocumab in people with hypercholesterolemia met their primary efficacy endpoint of a greater percent reduction from baseline in low-density lipoprotein cholesterol at 24 weeks compared to placebo or active comparator.
Wed Jul 30, 2014
Applied Clinical Trials
Sanofi and Regeneron Report Positive Top-Line Results from Nine Phase ...
Alirocumab is an investigational monoclonal antibody targeting PCSK9 . In the nine ODYSSEY trials, the mean percent reduction in LDL-C from baseline at 24 weeks in alirocumab-treated patients was consistent with results seen in previous alirocumab trials.